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ELENA PE, RN. J. ANTHONY COMES. MD. FACC: 
The prwnlalion. cardiac anatmny and utilily ol programmed 
vsnlricular slimulation in seven patients with sustained rentrku. 
lar tachymrdia associated with sarcoidoris are descriM. The 
mean patient age was 3S f S years. Pulmonary inwlwnent 
was apparrnl in three patienls and no rystemic manifestations 
ot rarcoidosis were prcwn( in one patient. &I patienfs had 
electmrardiographic abnormalities al rest and six had a lefl 
ventriudnt &Son fraction <&%. AU wwn patients had left 
venlricular wall motion abnormalities and lbe had mitral whe 
dysfunction. 
Four patients had an aulomatic cardin\-erter-dPfibrillalor im- 
planted uad rcceivd druz Iberap~: all fnur receiwd apprc@ie 
shucks. 
Sustairwl ventrirulsr tacbpcardia HBI easily inductd in nil 
patienis. Spanlaneous sustained ventricular tachgcardia was not 
prevented with corticostemid administraiion. Lkspite antiar- 
rbythmie drug therapy, two pnlienls bud sudden cardiac drarh 
and an additional four had recurrence ofventriadw tach~cardia, 
This report represents the large.esl dwrip#ire seer& of consa- 
utive patienls Mth sustained venlricular bwhyrardia awciaWd 
with sarcoidasir. Antiarrh~thmic drug therapy ot rentr%Aar 
laeh!eardia in patients with sarcaidosi% even when guided with 
programmed rcalrieular slinndation. is awxialed with a high 
rate of arrh>lhmir recurrence or rndden death. or b&h. Thus, 
implantation of an autumalic sntilxb?_cardia device (cwdio- 
wrter~delibrillaturl should be considered as primary therapy in 
such patients. Furlhwmore. rarcoidoris rhould be excluded, wilh 
Kreim skin testing if nece%sary. in any p&m with sustained 
rentricular tathycardia of unknown origin. 
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Ahbough cardiac involvemem wirh sarcoidosih ha> been 
rscognired for >60 years (II. the fiw arrhythmia attrlhuted 
to myocardial involvement with sarcuid granuloma WE 
reported approximately SO year; ago. Suhquenrly. 3 215: 
to 27% incidence rate of myucardial involvement has been 
reported GSr in patiems wth uthcr cvldence of sarcoidobi\ 
at aulop:y. However. only approximately 5% ofthosc round 
lo have noncaseating granulomu in the heart ;It autopsy have 
been reportell to have had apparent cardiac involvement 
before dtath. 
When arrhylhmias hnve been detected. heart b!ock has been 
olh~ervcd in up to 30% ofpatients. supravcntricular anhyth- 
mras in claw to 40% and ventricular ecropic beats in 
approximately 23% GBI. Ow series (91 reported a 23x5 
incidence of vcntriculararrbvthmirs in patientr with sarcoid- 
osih: however. rhc presence of swained ventricular tachy- 
cxdia wiis not determined. 
Common presenlation* ol’ cardiac wrcwi involvcmcnt 
include congestive heart failure awxiatud with let1 vcntric. 
ular systolic dysfunction and cardiac rhythm di~turbanoe~. 
Sudden death has been reponed 171 in up to 67% of 
palicnr\ wth myocardial sarcoidasis diagnosed after death: 
howcvcr. the mcidcncc of lethal ventricular tachyarrhytk- 
m~as :I, uppowd to fatal complete heart block. dcctrome- 
chan~al dissociation and embo!ic phenomena in this sub- 
group &patients has not been determined. Furthermore. the 
therapy and course of rustained ventricular tachyarrhyth- 
unia\ m patients with sarcuidosi> have only been explored in 
mrc CRX reports (10-15). Thus. the pmcnt series describes 
rkc underlying cardiac anatomy and the prospective ulility of 
pmgr;lmmed ventricular stimulation. drug therapy and im- 
plant;~h!e antilachycardia devices in seven consecutive pa- 
tients with sustained ventricular rachycnrdia associated with 
rercoldoGs_ 
Methods 
Study paiients. Seven ronsxutive patients with hemody- 
namically compromising ventricular tachycardia and docu- 
mented (n = 6) or highly :,o\nected In = II sarcoidosis 
underwent arrh~lhmia evaluation. Technelium.99m nuclear 
galed blond pool vem;iculography and two-dimensional 
echocardiography wtth Doppler evalualion were performed 
in all patienir: four pnrients underweru percutaneous trans- 
vcuous cndomyocardial biopsy. 
Electraphysiologic study. All patients subsequently un- 
derwent electrophysiologic invcsti@ion as previously de- 
scribed (161. Programmed ventricular stimulatton was per- 
formed with single and double premature extrastimuli 
delivcrcd al two basic drive cycle lcngrhr 1600 and 450 or 
400 ms) and burst ventricular pacing to a cycle length of 
240 mb from the richt ventricular aaex and rieht ventricular 
outflow tract. lntravencus infusion of isoproterenol. triple 
extrastimuli or left venlricula’ stimulation were not required 
to induce venlricular tachycardia in any patient. All baseline 
studies were conducisd in the abscncc of antiarrhythtnic 
agents. except in two patients who required such agents IO 
suppress Frcqucnt recurrent episodes ol’tachycardia. 
Clinical characterislics (Tah!e It. “Jtc patienls ranged in 
aae from 27 to 48 years (mean are 3S ? 8 at the time of 
referral). Four OF rhe seven palienrs wcrc men; five were 
black. one was white and one was Hispanic. Pulmonary 
involvement was present in four of the seven patients. two 
had ophthalmologic or central nervous system involvement. 
one had cmaneous involvemen and on? had no evidence of 
systemic disease. 
Diagnosis of sarcoidoiis. Four of the padems (Cases I, 3, 
5 and 71 had had docum:nted sarcoidosis for 2 mwths to 22 
years before invasive eb:ctmphysiologic assessment. Two of 
these four had a histori of nonsustained ventricular taLhy- 
cardia at the time sari.oidosis was diagnosed. Extracardiac 
involvement was pre.ent in all four patients: two had pul- 
monary Involvemenr, one had lupus pcrneo and one had 
characteristic uveiti., Sarcoidosis was confirmed by means 
of Kveim skin testing in two of these four patients and by 
skin biopsy in the patient with lupus perneo. The fourth 
patienl. although having characteristic uveal findings, re- 
fused fu~lher medical evaluation. 
Tic remaining three patients (Cases 5.4 and 6) presenled 
with sustained ventricular tachycardia and were subse- 
quently found to have sarcoidosir during their hospitaliza- 
tion. Patient 4 had pulmonary involvement and a diagnostic 
Kveim test: Patient 2 had lung involvement. uveitis. optic 
nerve involvement and a diagnostic transbronchial biopsy. 
Patient 6 had no systemic findings. He had a diagnostic 
scalene node biopsy at the time of rhoracotomy for implan- 
tation of an auromalic cardiovcrtcr-defibrillator and subse- 
quently developed roentgenographic findings consistent with 
slage I sarcoidosis. 
Eleclroeardiagrapbic findings (Table 2). Baseline electro- 
cardiograms (ECC; revested tall R waves in lead V, in two 
patients and right axis deviaiica \ugpestive of disturbed right 
venlricular activation in one patjent. Inferior or lateral ST 
segment and T wave changes, or both, were seen in three 
additional patients. No patient had atrioventricular (AV) 
block or evidence of sinus node dysfunc?lon. Presenting 
arrhythmias included sustained ventriculsc tachycardia re- 
quiring intervenlion for termination in six palients and 
frequent episodes of nonsustained ventricular tachycardia 
associated with prcsyncopal sensatio>is in the seventh. The 
spontaneous ventricular taehycardia had a tight bundle 
branch block configuration in each EBS~. 
Clinical evaluatloit (Table 3). The mean left ventricular 
ejection fraction delcrmined by technellum-99m-labeled 
gated blood pool imaging wab 34 + 8%. ‘Table 3 summarizes 
Ihe noninvasive findinsl with respect to ventricular wall 
motion and vslvular SIBUS. The !et”t ventricular ejecrion 
fraclinn was abnormal (445%) in six of the SCYCB patients. 
Discrete akinetic or dyskinetic left ventricular regions. or 
both. were documented in four patients. The other three 
patients had hypokinetic left venlricular contractile regions. 
Right ventricular itypokinesia was also present in four pa- 
tients. 
Tujo-dimerlsinr;nl rchnmdiogr~~phy performed whh con- 
tinuous and pulse:: wave Doppler assessment revealed mitral 
valve prolapse in association with a mild :o moderate degree 
of milral regurgitation in two p;lt~ents. Of the other fixc 
patients. three had a modcrate degree of murnl regurgiradon 
and IWO had no disturbance of mhral wlvc function. 
Invasivestudies. No patient had chest discomfort sug&ea- 
tive of angina pectoris. Coronary angiugnrphy did not reveal 
significant coronary artery stenoses in the four patient< who 
undetwenl this study. Furthermore. m the fwr patient% \\ho 
underwent percutaneous trinsvenous righl ventricular bi- 
opsy, no diagnostic gronulomas were observed. 
Eledmpbysiologic evsluation and drug therapy (Table 4. 
No patient had documented His-Purkwje conduction delay. 
Clinically significant wsrained monomorphic ventricular 
tachycardia was induced with a relatively nona_&re\s~e 
stimulation protocol: a single exlrasltmulus in four patients 
and double extrastimuli in three. Figure I illustrate\ induc- 
tion of sustained ventricular tachycardla m PaWnI I with 
two premalure ventricular stimuli. 
Five patients underwent serial electrophysiologic tc\iin$ 
wilh antiarrhythmic drugs. Four of there patients Imderwenl 
serial studies after loading with five or more anthrrhythmic 
agents, alone or in various combinwons. In rhcse four 
patient\. an ;m!iarrhythmir drug repimen rhar supprwed 
~i.ducl~on of ~cntricular lxh!cardw WI\ ~our.d. A fifth 
pa’lcnr IPulienr 3) was discharged on a corr.hlnation of 
qum~Ilnc and me~delinc. which risnificantly Icn$hcned the 
cycle Icnglh ul’the induced twhycardia from Jo0 to hW ms. 
Of the two remaining patients. one (Patient 51 r&cd 
followup electrophywlogic ierting and t\as dinchargrd 
from the hurpltal on treatment Hith quinidine. meviletine 
;utd propr;utolol. Supprersion of much uf thi5 patiem‘s 
amhlcnt ecwpio acrwiry ~a\ documented by conlinuuus 
ECG tclcmcwy muniloring. An automillic cardioverler- 
dcfibrill~lur U:L$ implanted a\ primsry preventiw therapy in 
;I wenth p:~twtt after induchun of sustained ventricular 
rxhywrdid. Episudca ofnonwstmned ventricular rachwr- 
di:l uere abolished eith me&Ate in this patient. 
l’ollo~?-up after electroph>siolopic evaluation. Rccur- 
rcncc\ of w\txincd wntricular tnchycardia were docu- 
menwd in fox padents. P;ltient\ I and 4. tn whom recurrent 
spontancuus *u&ned wntncular rachecardia developed 
dc\pitc elcclruph~s~ulopically gided antiarrhythmic thcr- 
ap), underwn~ implantmion of an automalic cardiovener- 
dctihritlawr and have recewed mult$e appropriale shocks. 
Both pilknt\ had documented wstaincd ventricular tachy. 
cardia hy ECG monitoring at the time of hospital discharge. 
Patients 6 and 7 also had automatic cardiovcrter.dcfibriIlator 
implantation before leaving the hospital and have received 
appropriate shocks. Patient 6. otherwise nol suspected of 
having WCOidOSiS. had a diagnostic scalene lymph node 
biopsy at the time of surgery and laier develuped chest X-ray 
findings consistent with stage 1 pulmonary involvement. 
Patient 7 had suppression of the inducible ~cntr~cttlar tachy- 
cardia with Bccainide: however. an automatic cardioverter- 
defibrillator was implanted because of the develuping con- 
cern about the unreliahiliiy of the :esuhn of programmed 
electrical stimulation in patients with tarcoidosis. 
A IiRh patient G?ttient 2) had had recurrent sustained 
ventricular lachycardia during therapy with quinidine and 
propranolol despite its suppression at programmed vcntric- 
ular stimulation. Induction of tachycardia wa, again con- 
trolled with quinidine and mexiletine: however. the patient 
experienced sudden cardiac death desphe compliance. An- 
other patient tPalient 5) had sudden death durmg nonclcc- 
trophy+alogically guided therapy. These two latter paiients 
had normal AV conduction with atrial pacing and no evi- 
Figutw I. Patent I. Suaained monomurphic vcnlricular lachycardia 
with o cycle length of 26” ms was induced wilh prcm~rturc Amuli 
delivered with LL ha+ drive trnin ofbw ms. HB = His bundle: L, = 
lead I; L? = lead II: S, = basic drive stimulus: S? = firat premature 
stimulus: S, = second premature stimulus: V, = precordiill lead V,. 
dence of infra-His or inlra-Hii5 block. Only one palient 
tf’aticm 31 has not had a clinically documented episode of 
sustained ventricular tachycardia during electrophysiologi- 
tally guided aniiarrhythmic therapy and is alive without an 
automalic cardioverter-defibrillator. This patienl’s present- 
ing arrhythmia was nonsustained ventricular tachycardia. 
Table 5 highlights the follow-up data from the time of the 
baseline elecirophysiologic studies. The total duration of 
follow-up from the initial electrophysiologic study. the clin- 
ical cotuse of recurrent arrhythmic events and the various 
antiarrhvthmic drum recimens tested are listed. The time to 
rccurrcncc r.nd implantation of an automatic cardioverter- 
defibrillator is indicated. Of note. Patients 6 and 7 received 
an implantable device before spontaneous recurrences, 
whereas Patients I and 4 received their device after recur- 
rent episodes were documented. Dr:pitc varying degrees of 
impaired Icf~ ventricular systolic dysfunction, only Patients 3 
and 4 have developed congestive beat failure. One of these 
tPatient 41 has requhed permanent pucemakcr insertion for 
control of marked sinus bradycardia. No patient has devel- 
oped significant AV conduction disturbances. 
Illustrative ease. Figure I demonstrates the induction of 
sustained ventricular tachycardia in Patient I. a 43-year old 
woman with a 22-year history of pulmonary sarcoidosis and an 
equally long history of nonsustained ventricular tachycardia 
before the development of spontaneous sustained ventricular 
tachycardia. Despite suppression of inducible ventricular 
tachycardia during electmphysiologic studies with procaine- 
mide and tocainide. as well as with quinidine and tocainide. she 
developed recurrent sustained ventricular tachycardia on both 
ofthese regimens. She undcrwcnt implantation ofan automatic 
cardiove~er-defibrillator I3 monlhs afterthe initial episode and 
has subsequently received at least live appropriate shocks 
(with documented recurrences of ventricular tachycardia) over 
the course of 2 years. 
Impact of corticosleroid lherapy. Five of the seven pa- 
tients were treated with oral prednisone at doses ranging 
from 30 to I% mglday during a period of 3 to 6 months. 
depending on the extent of noncardiac involvement. Recur- 
rences of ventriculat tachycardia or sudden death, or both. 
were documented in each of these patients ‘-2 munths after 
initiation of corticosteroid treatment. 
Discussion 
Myocardial sarcoidosis. The seven caw dcwrbcd in thr\ 
report represent a group of patient< with rustained ventric- 
ular tachycardia who had vttrioub prewttatiom of wcord- 
osis. Four had had systemic sarcoido\ir detected hrfore 
recognition of sustained ventriculilr tachycardia. The other 
three patients tiare classified as having extracardiac wcoid- 
osis subsequent lo presentation with the malignant arrhyth- 
mia. Right ventricular endomyocardial biopsy failed to dii. 
close noncaseating granuloma in my of the fourpatienr~ who 
underwent the procedure. However. hscau~e only 14% to 
30% of patients wtth myocardial satcoidws have hccn 
repotted (17.18) to have a diagnostic percutaneous tran\- 
v;nousendomyocardial biupsy. the finding in ottr sxic\ dot\ 
not speak against myocardial involveacnt. Bscaure of the 
high incidence with which myocardi:~l sarcoidosia may he 
missed on endomyocardial hiopby. repeat proccdurc\ have 
been recommended when its pre,ence is \trongly \u%pectcd 
(19). Although segtsental defects been un myocardial thal- 
lium-201 perfusion imaging at reht (Xl) and ditfuw uptake ~>n 
technetium pyroph ..sphote \conning L211 in patient\ rruh 
myocardial sxcoidosis might have been helpful. UC did nnt 
pursue such studies in our patients. 
Although right bundle branch h,uck \*;th prcwtt dunng 
sinu; rhythm in one patient. none had any si9nihcant form of 
AV block detected. In addition. a significant attial dtrhyth- 
mia(that is. atrial fluttery was rccurdcd in only one puticnt 
Electrocardiographic abnormalities zlt rc~~t wre dctect~d in 
all seven paticnls. This ;* nut wrpri\ing hcc;nw the prc\- 
ence of .tsymptomauc ECti abnornxlutc~ at re\t tn young 
patients with sy\tcmic wcordu& :md ne Jucunwnted myo- 
cardial involvement or other invohahle o.whitc procwer 
has been reported in up to 515f oi cases 123. 
h’wtcrrrcrtrirr~ g~,tnl~,r,r~ Ire\ hr,v,i ~~/~ww~~d br lhr CII. 
doawliwl. p~wiwr&ton IIII~ r~wrw~ior~rt. Such hion\ he- 
come sclerotic, rcwh in lo\\ of mywlr-dull tihcn ,rnd tnrn 
into bland scars. Wiihin the MI vc’ntwla. the mo?t cont. 
manly affected sites include the papillar? muwles. the myo- 
c,rrdwm adwcnt to the papillary muhcleh. the left vcntncu- 
lktr free ii,111 and the superior region of the intcrventricular 
rcptum tl-.i.?-91. In additwn. grxwluma~ surroundin; tntra- 
mural coronar! arteries have rarely been reported (231. 
‘;r;m~mural vxrrinp is common and left ventricular aneu- 
rywt formatton has been repotted r2.24 m >lO5i of patients 
n.i’n documcntcd cardiac sarcoid. 
Cardiac fttnction. ‘Tne presence of only mtld left venrric- 
ulx ~yrrolic dy4itnction in two of oui patients 129%1 con- 
trxhct~ the w$cstion of Roberts et al. 17) that extensive lefl 
ventricular rcarring is required for the development of 
w.t;uncd tcntrictdar tachycardia. Five pa!i:nir ti 1’41 rn our 
wri?\ h,rJ cvidsncc of both diiurhed mitral valve function 
;rnd wgmentai wall motion ahnormalities adjacmt to the 
rcgwn\ of on: N both papdlary muscles. Furthermore. three 
uf thckc tire patients had adjacent dyskinctic \cntricular 
wgnenr~ findings that correspond to the previously re- 
ported (I-6.X.W hrgh incidence of sarcotd ganulomatous 
inliltrntron of the popdlary mu&s and adjacent myocardinl 
scgtnent~ 4lthough endocardial electrode catheter mapptng 
~\a\ not performed. one might speculate that there regions 
were the or@t,uing sites of sustained venIricuIar tncbycar- 
dia. .At le.nt one case Jf wccessful treatment of sustained 
ventricular raehycardin with resection of a sincuid-related 
left ~cntocular anenrysm has been reported l!?i. 
Treatment of venlricular tachycardia. Suppression or 
~;ontro of vcntriculw tach~wtrdia induction. or both. was 
powhle rn id1 rive pattents.in whom it w’i attempted. Yet 
wr.tined ventricular tachycardta recurred in four of these 
p:uicntr. Biochemical ch*n.ges associated with sarcaidosis 
muy c\pl:un \ome ofrhc unreliability of antiarrhythmic drug 
c!licaci n wch patients. increased acidic alpha-plycopro- 
wn~. N hich in,+ alter free antiarrhythmic drug leveh.. have 
hccn dstcclcd in patents wilh wrcoidoair 1271. In addition, 
proawrive infiltration with grxnuloma or fibrosrs. or both. 
m,ty ,&c’r the underlyag at-rhythmic >ub\twte. 
Th,: c:rrly occurrence of sudden death in two of our 
p,uicnrs and the recurrence of wstamed ventr~ular tachy- 
c;~rth;t in tuo others led to implantation of an automatic 
c;lrdiovcrlcr-delibrlllator in two paiienrr aho had spontane- 
ou, and mducihle sustained monumurphx vcntrtcular tachy- 
cardia dc$pire the beneficial results of antiarrhythmrc drug 
therapy wgp~lcd from programmed vcntr~cular alimulation. 
SVithin 3 months of&vicc i~~pli~ntd.m, both patiNs had al 
Ica\t one shoch dehvered that wab considered 10 be appro- 
priate for tcrminaling a probable surlnined ventricular 
Iachyarrhylhmia Mat iu. preceding sympmms of regular 
rapid beating of the heart and significanl light-hcadcdncss or 
Jocumcnt&x of wstained venlricular !echycardial. 
One patient remains alive wilhoul implantalion of an 
automatic cardiovertcr-defibrilla[or or documented sponra- 
ncoub sustained I.cIIIricuIar tachycnrdia. This palient ini- 
tially prescntcd with nonw%lained ventricular Iachycardia 
awxlatcd with hght-hcadedncss and at prognmmcd ven- 
lricular Anolation had &I; induced swained monomor- 
phic ventricular txhycardia that was wppressed with u 
combination of quinidine and mexilcline. Thur. Ihe subse- 
quent risk fur \pontancous malignanl arrhylhmic evenls may 
differ in paticu1s with wcoidosia who present as this latter 
parient did. 
Previous studies. Our reporl dcscrihcs the largest series 
of patients wilh a diapnusis of sarcoidosi\ and symptomatic 
vetnricular techycardia. Although net documented in our 
series. the occurrence of susl;dned vemriculur lnchycardia in 
patienls wilh autopsy-proved barcoldosih has been awoci- 
ated with granuloma~ous infilrra~ion or scarring secondary to 
healing of granuloma. OF both (8). Our findings suppon 
previous observabons IY. IY.23) thal sustained venWicular 
tachycardia with ruspecwd myocardial inwlvcment occurs 
in a significanl number of patients who have no documented 
grorz pulmonary involvcmcnl lfor example. 43% of our 
patients). Sudden death has been nowd to be rhe imtial 
manifestation of cardiac involvement in 9% IU 35% of 
pz&nts with sarcoidork. In one autopsy kes (91. almost 
70% of palienlb who died ofcardiac rarcoidosis had no signs 
suggestive of sarcoidosis: however, X8% of those who died 
of cardiac rarcoidosis also had histologic lung involvcmcnr. 
Less obvious. oflen msidiuus system involvement (for cx- 
ample. c&meow and ophthalmolofiic) mny be the only clue 
10 the presence of sarcoidosis and should require confirma- 
tion hy liwe biopsy. Kvcim skm testing (25) or lvmph node 
hmpsy. 
Recommended treatment regintcn. Our findings lead us to 
speculare that home paricn~s with ventricular tachycardia 
and either no apparent hurt disease or assumed idiopathic 
Ml ventricular dysfuncrlon should undergo thorough c~lu- 
ation. including Kvcim skin testing. IU exclude the presence 
of sarcoido+ This may bc parliculnrly applicable to 
younger persons bccausc the mean age of 33 paticnls who 
died from myocardial sarcoidosis in one rcporwd series (26) 
ws 35 years. Even if amiarrhythmic agents thal wppresa 
induction of bustamed ventricular tachycardlo at pro- 
grammed stimulation are developed. implantation of an 
anrhachycardia device should he strongly considered (27). A 
recent report (281 describing four palicnl, rirh vcnlricular 
tachycardia and sarcoidosis supports Ihi> conwntion. 
~crm. cnrticosbxo!d administmdon did not prevent arrhylh- 
ma evcols in any of our patients. Although some reports 
(17.29) have suggested a role far corticosleroid administra- 
lion to control ventricular tachycardia awociated with sar- 
coido?i<, others (3,7.16,19,30.31) have found no conclusive 
be&r and even possible exacerbaGon of the arrhylhmias. 
Furlhcrmore. several inwwigatots (8) have suggested that 
corllcostemid use may hasten the development of left ven- 
wicular aneurysm formation in patienrs with myocardial 
sarcoido& In caxs of sustained ventricular tachycardia 
resistant IO steroids and arnianhyrhmic therapy, heart trans- 
plantation may be an alternative approach and has been 
rcportcd (19) to be successful in the absence ol’exwunyo. 
Eardial involvement. 
Limitations. This sludy has a few limilalions worthy of 
discursion. Fir% eleclrophysiologic lesling was performed 
withoul delermination of sinus node function in all patients 
hecause ventricular tachycardia had alre+y been docu- 
menmd. The IWO palicnt- who experienced sudder death 
had normal Hia-Purkinjr conduction al baseline study and 
with alrial pacing, Arrioventricular block in lhese parienls 
during atrial pacing occurred above the His bundle. Al- 
though sinus node dy,funcGon cannot be completely ex- 
eluded in these patients, it is highly improbable that this 
cmi~y could be implicated in the terminal events. 
Second. programmed ventricular stimulation was not 
performed with triple exlrastimuli in any patient. Further- 
more. none had left venlricular stimulation or programmed 
stimulation aner inlravenous infusion of isoproterenol. 
However. because all patients had sustained ventricular 
tachycardia induced with single or double extrastimuli. the 
need for more aggressive tesling at baseline study was 
uwwessary. On follow-up lest& more aggressive srimu- 
lation could lheorelically have suggested lack of arrhythmia 
suppression and predicted recurrences in some of the pa- 
licnls. 
Finally. because of differences in underlying len venwic- 
ular function and some individual patient responses, no 
%Isndard progrcshion of antiarrhythmic drug therapy was 
ulilized. However. in general. patients were first treated with 
a lype IA or IB anliarrhylhmic drug. followed by one or 
more combinaGons of these agems, and rhcn a type IC agenl 
if left venrricular \yuolic function permilted. If no responses 
or brcakihroughs occurred. anriarrhythmic therapy wilh 
soralol and finally amiodarone was artempled. 
Addendum 
Since submission of this manuscript. PaGent 3 developed 
recurrent. susiaincd monomorphic ventricular Iachycardia de- 
spite cnmpliance whh her anliarrhythmic drug regimen. Thus. 
20 months afier arrhythmia supprwion with quinidine and 
mexileiine was documcnled at programmed venlricular stimu- 
l&on. a CPI I660 aulumatic Fardioverter-defibnllator was 
implanted. Despite lre~lmenl whh amiodarone, the patient 

